VERTEX PHARMACEUTICALS INC / MA
Develops transformative medicines for serious diseases, specializing in cystic fibrosis.
VRTX | US
Overview
Corporate Details
- ISIN(s):
- US92532F1003
- LEI:
- Country:
- United States of America
- Address:
- 50 NORTHERN AVENUE, 2210 BOSTON
- Website:
- https://www.vrtx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vertex Pharmaceuticals is a global biotechnology company that discovers, develops, and commercializes transformative medicines for people with serious diseases. The company is a recognized leader in the treatment of cystic fibrosis (CF), having developed a portfolio of therapies that treat the underlying cause of the disease. Vertex focuses on scientific innovation and invests in research for specialty market diseases with high unmet medical needs, leveraging a deep understanding of causal human biology. Its research and development pipeline extends beyond CF to include other serious conditions such as sickle cell disease, beta-thalassemia, acute pain, and type 1 diabetes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all VERTEX PHARMACEUTICALS INC / MA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VERTEX PHARMACEUTICALS INC / MA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VERTEX PHARMACEUTICALS INC / MA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
